Potential use of lipoxygenase inhibitors for cancer chemoprevention

Bibliography

• HONN KV, TANG DG, GAO X et al.: 12-lipoxygenases and 12(S)-HETE: Role in cancer metastasis. Cancer Metastasis Rev. (1994) 13:365–396.
   PubMed Web of Science ®Google Scholar
• CHEN YQ, DUNIEC ZM, LIU B et al: Endogenous 12(S)-HETE production by tumor cells and its role in metastasis. Cancer Res. (1994) 54:1574–1579.
   PubMed Web of Science ®Google Scholar
• GAO X, GRIGNON DJ, CHBIHI T et al.: Elevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancer. Urology (1995) 46: 227–237.
   PubMed Web of Science ®Google Scholar
• TANG DG, HONN KV: 12-Lip oxygen ase, 12(S)-HETE and cancer metastasis. Ann. NY Acad. Sci. (1994) 744:199–215.
   PubMed Web of Science ®Google Scholar
• TIMAR J, RASO E, FAZAKAS ZS, SILLETTI S, RAZ A, HONN KV: Multiple use of a signal transduction pathway in tumor cell invasion. Anticancer Res. (1996) 16:3299–3306.
   PubMed Web of Science ®Google Scholar
• LIU B, TIMAR J, HOWLETT J, DIGLIO CA, HONN KV: Lipoxygenase metabolites of arachidonic and linoleic acids modulate the adhesion of tumor cells to endothelium via regulation of protein kinase C. Cell Regul. (1991) 2:1045–1055.
   PubMedGoogle Scholar
• HONN KV, TIMAR J, ROZHIN J et al: A lipoxygenase metabolite, 12(S)-HETE, stimulates protein kinase C-mediated release of cathepsin B from malignant cells. Exp. Cell Res. (1994) 214:120–130.
   PubMed Web of Science ®Google Scholar
• TANG DG, GROSSI IM, CHEN YQ, DIGLIO CA, HONN KV: 12(S)-HETE promotes tumor-cell adhesion by increasing surface expression of av133 integrins on~! endothelial cells. Int. J. Cancer (1993) 54:102–111.
   PubMed Web of Science ®Google Scholar
• GHOSH J, MYERS CE: Arachidonic acid stimulates prostate cancer cell growth: Critical role of 5-lipoxygenase. Biochem. Biophys. Res. Commun. (1997) 235:418–423.
   PubMed Web of Science ®Google Scholar
• NEEDLEMAN P, TURK J, JAKSCHIK BA, MORRISON AR, LEFKOWITH JB: Arachidonic acid metabolism. Ann. Rev. Biochem. (1986) 55:69–102.
   PubMed Web of Science ®Google Scholar
• LEWIS RA, AUSTEN KF, SOBERMAN RJ: Izukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl. J. Med. (1990) 323:645–655.
   Google Scholar
• PIPER PJ: lzukotrienes: Potent mediators of airway constriction. Int. Arch. Allergy Immunol. (1985) 76:43–48.
   Web of Science ®Google Scholar
• COLEMAN RA, EGLEN RM, JONES RL: Prostanoid and leukotriene receptors: A progress report from the IUPHAR working parties on classification and nomenclature. Adv. Prostaglandin Thromboxane Leukot. Res. (1995) 23:283–285.
   PubMedGoogle Scholar
• O'BYRNE PM: Exercise-induced bronchoconstriction: Elucidating the roles of leukotrienes and prosta-glandins. Pharmacotherapy (1997) 17:31S–38S.
   Google Scholar
• DRAZEN JM, AUSTEN KF: Izukotrienes and airway responses. Am. Rev. Respir. Dis. (1987) 136:985–998.
   PubMed Web of Science ®Google Scholar
• FUNK CD: The molecular biology of mammalian lipoxygenases and the quest for eicosanoid functions using lipoxygenase-deficient mice. Biochim. Biophys. Acta (1996) 1304:65–84.
   PubMed Web of Science ®Google Scholar
• OCHI K, YOSHIMOTO T, YAMAMOTO S, TANIGUCHI K, MIYAMOTO T: Arachidonate 5-lipoxygenase of guinea pig peritoneal polymorphonuclear leukocytes. J. Biol. Chem. (1983) 258:5754–5758.
   PubMed Web of Science ®Google Scholar
• ROUZER CA, SAMUELSSON B: On the nature of the5 -lipoxygenase reaction in human leukocytes: Enzyme purification and requirement for multiple stimulatory factors. Proc. Natl Acad. Sci. USA (1985) 82 :6040–6044.
   PubMed Web of Science ®Google Scholar
• ROUZER CA, KARGMAN S: Tran slo cation of 5-lipoxygenase to the membrane in human leukocytes challenged with ionophore A23187. j Biol. Chem. (1988) 263:10980–10988.
   PubMed Web of Science ®Google Scholar
• WOOD JW, EVANS JF, ETHIER D et al.: 5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes. J. Exp. Med. (1993) 178:1935–1946.
   PubMed Web of Science ®Google Scholar
• PETERS-GOLDEN M, MCNISH RW: Redistribution of5-lipoxygenase and cytosolic phospholipase A2 to the nuclear fraction upon macrophage activation. Biochem. Biophys. Res. Commun. (1993) 196:147–153.
   PubMed Web of Science ®Google Scholar
• WONG A, HWANG SM, COOK MN, HOGABOOM GK, CROOKE ST: Interactions of 5-lipoxygenase with membranes: Studies on the association of soluble enzyme with membranes and alterations in enzyme activity. Biochemistry (1988) 27:6763–6769.
   PubMed Web of Science ®Google Scholar
• BROCK TG, MCNISH RW, PETERS-GOLDEN M: Transloca-tion and leukotriene synthetic capacity of nuclear 5-lipoxygenase in rat basophilic leukemia cells and alveolar macrophages. J. Biol. Chem. (1995) 270:21652–21658.
   PubMed Web of Science ®Google Scholar
• WOODS JW, COFFEY MJ, BROCK TG, SINGER II, PETERS-GOLDEN M: 5-lipoxygenase is located in the euchro-matin of the nucleus in resting human alveolar macrophages and translocates to the nuclear envelope upon cell activation. j Clin. Invest. (1995) 95:2035–2046.
   PubMed Web of Science ®Google Scholar
• MAHMUD I, SUZUKI T, YAMAMOTO Y et al.: Induction of cyclooxygenase and suppression of 12-lipoxygenase in human erythroleukemia cells upon phorbol ester-induced differentiation. Biochim. Biophys. Acta (1993) 1166:211–216.
   PubMed Web of Science ®Google Scholar
• CHANG W-C, NING C-C, LIN MT, HUANG J-D: Epidermalgrowth factor enhances a microsomal 12-lipoxygenase activity in A431 cells. j Biol. Chem. (1992) 267:3657–3666.
   PubMed Web of Science ®Google Scholar
• BABA A, SAKUMA S, OKAMOTO H, INOUE T, IWATA H: Calcium induces membrane translocation of 12-lipoxygenase in rat platelets. j Biol. Chem. (1989) 264:15790–15795.
   PubMed Web of Science ®Google Scholar
• HAGMANN W, KAGAWA D, RENAUD C, HONN KV: Activity and protein distribution of 12-lip oxygenase in hel cells: Induction of membrane-association by phorbol ester TPA, modulation of activity by glutathione and 13-HPODE and Ca2±-dependent translocation to membranes. Prostaglandins (1993) 46:471–477.
   PubMed Web of Science ®Google Scholar
• NADEL JA, CONRAD DJ, UEKI IF, SCHUSTER A, SIGAL E: Immunocyto chemical localization of arachidon ate 15-lipoxygenase in erythrocytes, leukocytes and airway cells. J. Clin. Invest. (1991) 87:1139–1145.
   PubMed Web of Science ®Google Scholar
• NARUMIYA S, SALMON JA, COTTEE FH, WEATHERLEY BC, FLOWER RJ: Arachidonic acid 15-lipoxygenase from rabbit peritoneal polymorphonuclear leukocytes. J. Biol. Chem. (1981) 256:9583–9592.
   PubMed Web of Science ®Google Scholar
• YAMAMOTO S. Mammalian lipoxygenases: Molecular structures and functions. Biochim. Biophys. Acta (1992) 1128:117–131.
   PubMed Web of Science ®Google Scholar
• FUNK CD, FUNK LB, FITZGERALD GA, SAMUELSSON B: Characterization of human 12-lipoxygenase genes. Proc. Natl. Acad. Sci. USA (1992) 89:3962–3966.
   PubMed Web of Science ®Google Scholar
• TAKAHASHI Y, UEDA N, YAMAMOTO S: Two immuno-logically and catalytically distinct arachidonate 12-lipoxygenases of bovine platelets and leukocytes. Arch. Biochem. Biophys. (1988) 266:613–621.
   PubMed Web of Science ®Google Scholar
• WALSTRA P, VERHAGEN J, VERMEER MA, VELDINK GA,VLIEGENTHART JFG: Demonstration of a © Ashley Publications Ltd. All rights reserved.Exp. Opin. Invest. Drugs (2000) 9(9) 12-lipoxygenase activity in bovine polymorphonu-clear leukocytes. Biochim. Biophys. Acta (1987) 921:312–319.
   Google Scholar
• FUNK CD, FURCI L, FITZGERALD GA: Molecular cloning,primary structure and expression of the human platelet/erythroleukemia cell 12-lipoxygenase. Proc. Natl. Acad. ScL USA (1990) 87:5638–5642.
   PubMed Web of Science ®Google Scholar
• HADA T, UEDA N, TAKAHASHI Y, YAMAMOTO S: Catalytic properties of human platelet 12-lipoxygenase as compared with the enzymes of other origins. Biochim. Biophys. Acta (1991) 1083:89–93.
   PubMed Web of Science ®Google Scholar
• DE MARZO N, SLOANE DL, DICHARRY S, HIGHLAND E,SIGAL E: Cloning and expression of an airway epithe-lial 12-lip oxygen ase. Am. J. Physiol. (1 9 9 2) 2 62:L198–L207.
   Google Scholar
• WATANABE T, MEDINA JF, HAEGGSTROM JZ, RADMARK0, SAMUELSSON B: Molecular cloning of a 12-lipoxygenase cDNA from rat brain. Eur.J. Biochem. (1993) 212:605–612.
   PubMedGoogle Scholar
• YAMAMOTO S, SUZUKI H, UEDA N: Arachidonate 12-lipoxygenases. Prog. Lipid Res. (1997) 36:23–41.
   PubMed Web of Science ®Google Scholar
• SAMUELSSON B. lzukotrienes: mediators of immediatehypersensitivity reactions and inflammation. Science (1983) 220:568–575.
   PubMed Web of Science ®Google Scholar
• ABOU-EL-ELA SH, PRASSE KW, CARROLL R, WADE AE, DHARWADKAR S, BUNCE OR: Eicosanoid synthesis in 7,12-dimethylbenz(a)anthracene-induced mammary carcinomas in Sprague-Dawley rats fed primrose oil, menhaden oil or corn oil diet. Lipids (1988) 23:948–954.
   PubMed Web of Science ®Google Scholar
• ABOU-EL-ELA SH, PRASSE KW, FARRELL RL, CARROLL RW,WADE AE, BUNCE OR: Effects of D,L-2-difluoro-methylornithine and indomethacin on mammary tumor promotion in rats fed high n-3 and/or n-6 fat diets. Cancer Res. (1989) 49:1434–1440.
   PubMed Web of Science ®Google Scholar
• JURKOWSKI JJ, CAVE WT, JR.: Dietary effects ofmenhaden oil on the growth and membrane lipid composition of rat mammary tumors. J. Natl. Cancer Inst. (1985) 74:1145–1150.
   Google Scholar
• KARMALI RA, MARSH J, FUCHS C: Effect of t0-3 fatty acidson growth of a rat mammary tumor. J. Natl. Cancer Inst. (1984) 73:457–461.
   PubMed Web of Science ®Google Scholar
• KORT WJ, BIJMA AM, VAN DAM JJ et al: Eicosanoids inbreast cancer patients before and after mastectomy. Prostaglandins Leukot. Essent. Fatty Acids (1992) 45 :319–327.
   PubMed Web of Science ®Google Scholar
• NATARAJAN R, ESWORTHY R, BAI W, GU J-L, WILCZYNSKI S, NADLER J: Increased 12-lipoxygenase expression in breast cancer tissues and cells. Regula-tion by epidermal growth factor. J. Clin. Endocrinol. Metab. (1997) 82:1790–1798.
   Web of Science ®Google Scholar
• LIU X-H, CONNOLLY JM, ROSE DP: Eicosanoids asmediators of linoleic acid-stimulated invasion and Type IV collagenase production by a metastatic human breast cancer cell line. Clin. Exp. Metastasis (1996) 14:145–152.
   PubMed Web of Science ®Google Scholar
• ZHUANG Z-P, VORTMEYER AO, MARK EJ et al: Barrett'sesophagus: Metaplastic cells with loss of heterozy-gosity at the APC gene locus are clonal precursors to invasive adenocarcinoma. Cancer Res. (1996) 5 6:1961–1964.
   Google Scholar
• REDDY N, EVERHART A, ELING T, GLASGOW W: Charac-terization of a 15-lipoxygenase in human breast carcinoma BT-20 cells: Stimulation of 13-HODE formation by TGF-a/EGF. Biochem. Biophys. Res. Commun. (1997) 231:111–116.
   PubMed Web of Science ®Google Scholar
• JARDINES L, WEISS M, FOWBLE B, GREENE M: neu(c-erbB-2 THER2) and the epidermal growth factor receptor (EGFR) in breast cancer. Pathobiology (1993) 61:268–282.
   PubMed Web of Science ®Google Scholar
• FOX SB, SMITH K, HOLLYER J, GREENALL M, HASTRICH D,HARRIS AL: The epidermal growth factor receptor as a prognostic marker: Results of 370 patients and review of 3009 patients. Breast Cancer Res. Treat. (1994) 2 9:41–49.
   Web of Science ®Google Scholar
• MCCORMICK DL, SPICER AM: Nordihydroguaiaretic acidsuppression of rat mammary carcinogenesis induced by N-methyl-N-nitrosourea. Cancer Lett. (1987) 37:139–146.
   PubMed Web of Science ®Google Scholar
• KITAGAWA H, NOGUCHI M: Comparative effects of piroxicam and esculetin on incidence, proliferation and cell kinetics of mammary carcinomas induced by 7,12-dimethylbenz[a]anthracene in rats on high- and low-fat diets. Oncology (1994) 51:401–410.
   PubMed Web of Science ®Google Scholar
• MATSUNAGA K, YOSHIMI N, YAMADA Y etal.: Inhibitory effects of nabumetone, a cyclooxygenase-2 inhibitor and esculetin, a lipoxygenase inhibitor, on N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats. Jpn. J. Cancer Res. (1998) 89:496–501.
   Google Scholar
• BORTUZZO C, HANIF R, KASHFI K, STAIANO-COICO L, SHIFF SJ, RIGAS B: The effect of leukotrienes B and selected HETEs on the proliferation of colon cancer cells. Biochim. Biophys. Acta (1996) 1 3 00:240–246.
   Google Scholar
• HUSSEY HJ, TISDALE MJ: Inhibition of tumour growth by lipoxygenase inhibitors. Br. J. Cancer (1996) 7 4:683–687.
   Web of Science ®Google Scholar
• CORTESE JF, SPANNHAKE EW, EISINGER W, POTTER JJ,YANG VW: The 5-lipoxygenase pathway in cultured human intestinal epithelial cells. Prostaglandins (1995) 49:155–166.
   PubMed Web of Science ®Google Scholar
• SJOLANDER A, SCHIPPERT A, HAMMARSTROM S: A human epithelial cell line, intestine-407, can produce 5-hydroxyeicosatetraenoic acid and leukotriene 134. Prostaglandins (1993) 45:85–96.
   PubMed Web of Science ®Google Scholar
• DIAS VC, WALLACE JL, PARSONS HG: Modulation ofcellular phospholipid fatty acids and leukotriene B4 synthesis in the human intestinal cell (CaCo-2). Gut (1992) 33:622–627.
   PubMed Web of Science ®Google Scholar
• CRAVEN PA, DERUBERTIS FR: Profiles of eicosanoidproduction by superficial and proliferative colonic epithelial cells and sub-epithelial colonic tissue. Prostate (1986) 32:387-399. © Ashley Publications Ltd. All rights reserved.Exp. Opin. Invest. Drugs (2000) 9(9)
   Google Scholar
• GAO X, HONN KV: Biological properties of 12(S)-HETE in cancer metastasis. Adv. Prostaglandin Thromboxane Leukot. Res. (1995) 23:439–444.
   PubMedGoogle Scholar
• MEYERS CE, GHOSH J: lipoxygenase inhibition in prostate cancer. Eur. Urol. (1999) 35:395–398.
   PubMed Web of Science ®Google Scholar
• ANDERSON KM, SEED T, VOS M et al.: 5-lipoxygenase inhibitors reduce PC-3 cell proliferation and initiate nonnecrotic cell death. Prostate (1998) 37:161–173.
   PubMed Web of Science ®Google Scholar
• GHOSH J, MYERS CE: Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. Proc. Natl. Acad. Sci. USA (1998) 95:13182–13187.
   PubMed Web of Science ®Google Scholar
• ANDERSON KM, SEED T, ONDREY F, HARRIS JE: The selective 5-lip oxygenase inhibitor A63162 reduces PC3 proliferation and initiates morphologic changes consistent with secretion. Anticancer Res. (1994) 1 4:1951–1960.
   Google Scholar
• MOODY TR, LEYTON J, MARTINEZ A, HONG S, MALKINSON A, MULSHINE JL: lipoxygenase inhibitors prevent lung carcinogenesis and inhibit non-small cell lung cancer growth. Exp. Lung Res. (1998) 2 4:617–628.
   Web of Science ®Google Scholar
• RIOUX N, CASTONGUAY A: Inhibitors of lipoxygenase: A new class of cancer chemopreventive agents. Carcinogenesis (1998) 19:1393–1400.
   PubMed Web of Science ®Google Scholar
• AVIS IM, JETT M, BOYLE T et al.: Growth control of lung cancer by interruption of 5-lip oxygenase-mediated growth factor signaling. j Clin. Invest. (1996) 97:806–813.
   PubMed Web of Science ®Google Scholar
• KRIEG P, KINZIG A, RESS-LOSCHKE M et al.:12-lipoxygenase isoenzymes in mouse skin tumor development. Mot. Carcinog. (1995) 14:118–129.
   PubMed Web of Science ®Google Scholar
• CHANG W-C, LIU Y-W, NING C-C, SUZUKI H,YOSHIMOTO T, YAMAMOTO S: Induction of arachido-nate 12-lipoxygenase mRNA by epidermal growth factor in A431 cells. J Biol. Chem. (1993) 268:18734–18739.
   PubMed Web of Science ®Google Scholar
• CHEN B-K, LIU Y-W, YAMAMOTO S, CHANG W-C: Overexpression of Ha-ras enhances the transcription of human arachidonate 12-lipoxygenase promoter in A431 cells. Biochim. Biophys. Acta (1997) 1344:270–277.
   PubMed Web of Science ®Google Scholar
• LEPLEY RA, MUSKARDIN DT, FITZPATRICK FA: Tyrosinekinase activity modulates catalysis and translocation of cellular 5-lipoxygenase. J. Biol. Chem. (1996) 271:6179–6184.
   PubMed Web of Science ®Google Scholar
• WANG X-Q, OTSUKA M, TAKAGI J, KOBAYASHI Y, SATO F, SAITO Y: Inhibition of adenylyl cyclases by 12(S)-hydroxyeicosatetraenoic acid. Biochem. Biophys. Res. Commun. (1996) 228:81–87.
   PubMed Web of Science ®Google Scholar
• HAGERMAN RA, SMITH TJ, LOCNISKAR MF: lipoxyge-nase metabolites activate protein kinase C. FASEBJ. (1993) 7:A601. Abstract 3479.
   Google Scholar
• LIU Y-W, CHEN B-K, CHEN C-J et al.: Epidermal growth factor enhances transcription of human arachidonate 12-lipoxygenase in A431 cells. Biochim. Biophys. Acta (1997) 1344:38–46.
   PubMed Web of Science ®Google Scholar
• O'DONNELL VB, SPYCHER S, AZZI A: Involvement ofoxidants and oxidant-generating enzyme(s) in tumour-necrosis-factor-a-mediated apoptosis: Role for lipoxygenase pathway but not mitochondrial respiratory chain. Biochem. J. (1995) 310:133–141.
   PubMed Web of Science ®Google Scholar
• HANSSON A, SERHAN CN, HAEGGSTROM J, INGELMAN-SUNDBERG M, SAMUELSSON B: Activation of protein kinase C by lipoxin A and other eicosanoids. Intracel-lular action of oxygenation products of arachidonic acid. Biochem. Biophys. Res. Commun. (1 9 8 6) 1 3 4:1215-1222.
   Google Scholar
• LIU B, MAHER RJ, HANNUN YA, PORTER AT, HONN KV:12(S)-HETE enhancement of prostate tumor cell invasion: Selective role of PKCa. J Natl. Cancer Inst. (1994) 86:1145–1151.
   PubMed Web of Science ®Google Scholar
• SOLANO AR, DADA L, PODESTA EJ: Lipoxygenase products as common intermediates in cyclic AMP-dependent and -independent adrenal steroido-genesis in rats. j Mot. Endocrinol. (1988) 1:147–154.
   PubMed Web of Science ®Google Scholar
• HAGMANN W: Cell proliferation status, cytokine actionand protein tyrosine phosphorylation modulate leukotriene biosynthesis in a basophil leukaemia and a mastocytoma cell line. Biochem. J. (1994) 299:467–472.
   PubMed Web of Science ®Google Scholar
• SCHADE UF, ERNST M, REINKE M, WOLTER DT: lipoxy-genase inhibitors suppress formation of tumor necrosis factor in vitro and in vivo. Biochem. Biophys. Res. Commun. (1989) 159:748–754.
   PubMed Web of Science ®Google Scholar
• DETHLEFSEN SM, SHEPRO D, D'AMORE PA: Arachidonicacid metabolites in bFGF-, PDGF- and serum-stimulated vascular cell growth. Exp. Cell. Res. (1994) 21 2:262–273.
   Web of Science ®Google Scholar
• PEPPELENBOSCH MP, TERTOOLEN LGJ, DEN HERTOG J,DE LAAT SW: Epidermal growth factor activates calcium channels by phospholipase A2 /5-lipoxygenase-mediated leukotriene C4 produc-tion. Cell (1992) 69:295–303.
   PubMed Web of Science ®Google Scholar
• CRAWFORD D, ZBINDEN I, AMSTAD P, CERUTTI P: Oxidant stress induces the proto-oncogenes c-fos and c-myc in mouse epidermal cells. Oncogene (1988) 3:27–32.
   Web of Science ®Google Scholar
• THOMPSON TC: Growth factors and oncogenes in prostate cancer. Cancer Cells (1990) 2:345–354.
   PubMed Web of Science ®Google Scholar
• TANG DG, CHEN YQ, HONN KV: Arachidonate lipoxy-genases as essential regulators of cell survival and apoptosis. Proc. Natl. Acad. Sci. USA (1996) 93:5241–5246.
   PubMed Web of Science ®Google Scholar
• BUTTKE TM, SANDSTROM PA: Oxidative stress as amediator of apoptosis. Immunol. Today (1994) 15:7–10.
   PubMedGoogle Scholar
• ANDERSON KM, SEE TM, PENG J, JAJEH A, MENG J, HARRIS JE: Morphologic changes of apoptosis induced in human chronic myelogenous leukemia 'blast' cells by 5C41661A (Searle), a selective inhibitor of 5-lip oxygenase. Scanning Microsc. (1994) 8:675–686.
   PubMedGoogle Scholar
• BROOKS CDW, SUMMERS JB: Modulators of leukotrienebiosynthesis and receptor activation. J Med. Chem. (1996) 39:2629-2654. © Ashley Publications Ltd. All rights reserved.Exp. Opin. Invest. Drugs (2000) 9(9)
   Google Scholar
• KULKARNI AP, CAI Y, RICHARDS IS: Rat pulmonarylipoxygenase: Dioxygenase activity and role in xenobiotic metabolism. Int. J. Biochem. (1992) 24:255–261.
   PubMedGoogle Scholar
• NEMOTO N, TAKAYAMA S: Arachidonic acid-dependentactivation of benzo[a]pyrene to bind to proteins with cytosolic and microsomal fractions from rat liver and lung. Carcinogenesis (1984) 5:961–964.
   PubMed Web of Science ®Google Scholar
• TIMAR J, SILLETTI S, BAZAZ R, RAZ A, HONN KV: Regula-tion of melanoma-cell motility by the lipoxygenase metabolite 12 -(S)-HETE. Int. J. Cancer (19 9 3) 55:1003-1010.
   Google Scholar
• FORD-HUTCHINSON AW, BRAY MA, DOIG MV, SHIPLEYME, SMITH MJH: Izukotriene B, a potent chemokinetic and aggregating substance released from polymor-phonuclear leukocytes. Nature (1980) 286:264–265.
   PubMed Web of Science ®Google Scholar
• STRASSER TH, FISCHER S, WEBER PC: Inhibition ofleukotriene B4 formation in human neutrophils after oral nafazatrom (Bay g 6575). Biochem. Pharmacol. (1985) 34:1891–1894.
   PubMed Web of Science ®Google Scholar
• KESHAVARZIAN A, SEDGHI S, KANOFSKY J et al.:Excessive production of reactive oxygen metabolites by inflamed colon: Analysis by chemiluminescence probe. Gastroenterology (1992) 103:177–185.
   PubMed Web of Science ®Google Scholar
• PAPADOGIANNAKIS N, BARBIERI B: Lipoxygenase inhibitors counteract protein kinase C mediated events in human T lymphocyte proliferation. Int. J Immunopharmacol. (1997) 19:263–275.
   PubMed Web of Science ®Google Scholar
• FORD-HUTCHINSON AW, GRESSER M, YOUNG RN: 5-lipoxygenase. Ann. Rev. Biochem. (1994) 63:383–417.
   PubMed Web of Science ®Google Scholar
• KENSLER TVV, TRUSH MA, GUYTON KZ: Free radicals astargets for cancer chemoprevention: Prospects and Problems. In: Cellular and Molecular Targets for Chemoprevention. Steele VE, Stoner GD, Boone CW, Kelloff GJ (Eds.), CRC Press, Boca Raton, FL, USA (1992):173–191.
   Google Scholar
• NIE D, TANG K, DIGLIO C, HONN KV: Eicosanoid regula-tion of angiogenesis: Role of endothelial arachidonate 12-lipoxygenase. Blood (1995) 95:2304–2311.
   Google Scholar
• TANG DG, RENAUD C, STOJAKOVIC S, DIGLIO CA, PORTER A, HONN KV: 12 (S)-HETE is a mitogenic factor for microvascular endothelial cells: Its potential role in angiogenesis. Biochem. Biophys. Res. Commun. (1995) 211:462–468.
   PubMed Web of Science ®Google Scholar
• SETTY BNY, GRAEBER JE, STUART MJ: The mitogenic effect of 15- and 12-hydroxyeicosatetraenoic acid on endothelial cells may be mediated via deacylglycerol kinase inhibition. j Biol. Chem. (1987) 262:17613–17622.
   PubMed Web of Science ®Google Scholar
• NIE D, HILLMAN GG, GEDDES T et al.: Platelet-type 12-lipoxygenase in a human prostate carcinoma stimulates angiogenesis and tumor growth. CancerRes. (1998) 58:4047–4051.
   Web of Science ®Google Scholar
• IZUMI T, HOSHIKO S, RADMARK O, SAMUELSSON B: Cloning of the cDNAfor human 12-lipoxygenase. Proc. Natl. Acad. Sci. USA (1990) 87:7477–7481.
   PubMed Web of Science ®Google Scholar
• WEITZMAN SA, GORDON LI: Inflammation and cancer: Role of phagocyte-generated oxidants in carcino-genesis. Blood (1990) 76:655–663.
   PubMed Web of Science ®Google Scholar
• WISEMAN H, HALLIWELL B: Damage to DNA by reactive oxygen and nitrogen species: Role in inflammatory disease and progression to cancer. Biochem. J (1996) 313:17–29.
   PubMed Web of Science ®Google Scholar
• CARTER GW, YOUNG PR, ALBERT DH et al.: 5-Lipoxygenase inhibitory activity of zileuton. J. Pharmacol. Exp. Ther. (1991) 256:929–937.
   PubMed Web of Science ®Google Scholar
• BROOKS CDW, STEWART AO, BASHA A et al.: (R)-(+)- N- [3 -[5 -[(4 -fluor op hen yl)m ethyl]-2-thieny1]-1 -methyl-2-propyny1]-N-hydroxyurea (ABT-761), a second-generation 5 -lipoxygenase inhibitor. J. Med. Chem. 38 (1995) 38:4768-4775.
   Google Scholar
• YOSHIMOTO T, YOKOYAMA C, OCHI K et al.: 2,3,5 -Trimethy1-6-(12-hydroxy-5,10-dodecadiyny1)-1,4-benzoquinone (AA861), a selective inhibitor of the 5-lipoxygenase reaction and the biosynthesis of slow-reacting substance of anaphylaxis. Biochim. Biophys. Acta (1982) 713:470–473.
   PubMed Web of Science ®Google Scholar
• NAKADATE T, YAMAMOTO S, AIZU E, KATO R: Inhibi-tion of mouse epidermal 12-lipoxygenase by 2,3,4-trimethy1-6-(12-hydroxy-5,10-dodecadiyny1)-1, 4-benzoquinone (AA861). J. Pharm. Pharmacol. (1985) 37:71–73.
   PubMed Web of Science ®Google Scholar
• WALKER ERH: The design of therapeutically effective 5-lipoxygenase inhibitors. Eur. J Med. Chem. (1995) 30:5399–S416.
   Web of Science ®Google Scholar
• GILLARD J, FORD-HUTCHINSON AW, CHAN C et al.: L-663,536 (MK-886) (341 -(4-chlor obenzy1)-3-t-butylthio -5 -isop r op ylin do1-2 -y1]-2,2 -dimethyl propanoic acid), a novel, orally active leukotriene biosynthesis inhibitor. Can. J. Physiol. Pharmacol. (1989) 67:456–464.
   PubMed Web of Science ®Google Scholar
• BRIDEAU C, CHAN C, CHARLESON S et al: Pharmacology of MK-0591 (341-(4-chlorobenzy1)-3-(t-butylthio)-5-(quin olin-2-yl-methoxy)-in do1-2 -y11-2,2 -dimethyl propanoic acid), a potent, orally active leukotriene biosynthesis inhibitor. Can. J. Physiol. Pharmacol. (1992) 70:799–807.
   PubMed Web of Science ®Google Scholar
• MULLER-PEDDINGHAUS R, FRUCHTMANN R, AHR H-J et BAYX1005, anew selective inhibitor of leukotriene synthesis: Pharmacology and pharmacokinetics. j Lipid Mediat. (1993) 6:245–248.
   PubMedGoogle Scholar
• DJURIC SW, COLLINS PW, JONES PH et al.: 7-[344-Acetyl-3-methoxy-2-propylphenoxy)pro-poxy]-3,4-dihydro-8-propy1-2H-1-benzopyran-2-carboxylic acid: An orally active selective leukotriene B4 receptor antago-nist. J. Med. Chem. (1989) 32:1145–1147.
   PubMed Web of Science ®Google Scholar
• TSAI BS, KEITH RH, VILLANI-PRICE D et al.: The in vitro pharmacology of SC-51146: A potent antagonist of leukotriene B4 receptors. J Pharmacol Exp. Ther. (1994) 2 68:1499–1505.
   Google Scholar
• KRELL RD, AHARONY D, BUCKNER CK et al.: The preclinical pharmacology of ICI 204,219. A peptide leukotriene antagonist. Am. Rev. Respir. Dis. (1990) 141:978-987. © Ashley Publications Ltd. All rights reserved.Exp. Opin. Invest. Drugs (2000) 9(9)
   Google Scholar
• SEKIYA K, OKUDA H, ARICHI S: Selective inhibition of platelet lipoxygenase by esculetin. Biochim. Biophys. Acta (1982) 713:68–72.
   PubMed Web of Science ®Google Scholar
• KIMURA Y, OKUDA H, ARICHI S, BABA K, KOZAWA, M: Inhibition of the formation of 5-hydroxy-6,8,11,14-eicosatetraenoic acid from arachidonic acid in polymorphonuclear leukocytes by various coumarins. Biochim. Biophys. Acta (1985) 834:224–229.
   PubMed Web of Science ®Google Scholar
• NEICHI T, KOSHIHARA Y, MUROTA S-I: Inhibitory effect of esculetin on 5-lipoxygenase and leukotriene biosynthesis. Biochim. Biophys. Acta (1983)753:130–132.
   PubMed Web of Science ®Google Scholar
• HUANG H-C, HSIEH L-M, CHEN H-W, UN Y-S, CHEN J-S: Effects of baicalein and esculetin on transduction signals and growth factors expression in T-lymphoid leukemia cells. Eur. j Pharmacol. (1994) 68:73–78.
   Google Scholar
• HUANG H-C, LAI M-W, WANG H-R, CHUNG Y-L, HSIEH L-M, CHEN C-C: Antiproliferative effect of esculetin on vascular smooth muscle cells. Possible roles of signal transduction pathways. Eur. J. Pharmacol. (1993) 237:39–44.
   Google Scholar
• EARASHI M, NOGUCHI M, KINOSHITA K, TANAKA M: Effects of eicosanoid synthesis inhibitors on the in vitro growth and prostaglandin E and leukotriene B secretion of a human breast cancer cell line. Oncology (1995) 52:150–155.
   PubMed Web of Science ®Google Scholar
• NOGUCHI M, KITAGAWA H, MIYAZAKI I, MIZUKAMI Y: Influence of esculetin on incidence, proliferation and cell kinetics of mammary carcinomas induced by 7,12-dimethylbenz[a]anthracene in rats on high- and low-fat diets. Jpn. J. Cancer Res. (1993) 84:1010–1014.
   PubMedGoogle Scholar
• REICH R, MARTIN GR: Identification of arachidonic acid pathways required for the invasive and metastatic activity of malignant tumor cells. Prostaglandins (1996) 51:1–17.
   PubMed Web of Science ®Google Scholar
• SEKIYA K, OKUDA H: Selective inhibition of platelet lipoxygenase by baicalein. Biochem. Biophys. Res. Comm. (1982) 105:1090–1095.
   PubMed Web of Science ®Google Scholar
• BUTENKO IG, GLADTCHENKO SV, GALUSHKO SV: Anti-inflammatory properties and inhibition of leukotriene C4 biosynthesis in vitro by flavonoid baicalein from Scutellaria baicalensis Georgy roots. Agents Actions (1993) 39:C49–051.
   PubMedGoogle Scholar
• MOTOO Y, SAWABU N: Antitumor effects of saikosa-ponins, baicalin and baicalein on human hepatoma cell lines. Cancer Lett. (1994) 86:91–95.
   PubMed Web of Science ®Google Scholar
• SO FV, GUTHRIE N, CHAMBERS AF, CARROLL KK: Inhibi-tion of proliferation of estrogen receptor-positive MCF-7 human breast cancer cells by flavonoids in the presence and absence of excess estrogen. Cancer Lett. (1997) 112:127–133.
   PubMed Web of Science ®Google Scholar
• MARNETT LJ, LEITHAUSER MT, RICHARDS KM et al.: Arachidonic acid metabolism of cytosolic fractions of Lewis lung carcinoma cells. Adv. Prostaglandin Thromboxane LeukoL Res. (1991) 21B:895–900.
   PubMedGoogle Scholar
• HUANG F-C, SHOUPE TS, LIN J et al: Differential effects of a series of hydroxamic acid derivatives on 5-lipoxygenase and cyclooxygenase from neutrophils and 12-lipoxygenase from platelets and their in vivo effects on inflammation and anaphylaxis. J. Med. Chem. (1989) 32:1836–1842.
   PubMed Web of Science ®Google Scholar
• YAFFEE M, WALTER P, RICHTER C, MULLER M: Direct observation of iron-induced conformational changes of mitochondrial DNA by high-resolution field-emission in-lens scanning electron microscopy. Proc. Natl. Acad. ScL USA (1996) 93:5341–5346.
   PubMed Web of Science ®Google Scholar
• BELL RL, BROOKS DW, YOUNG PR et al: A-78773: A selective, potent 5-lipoxygenase inhibitor. J. Lipid MediaL (1993) 6:259–264.
   PubMed Web of Science ®Google Scholar
• AIZU E, NAKADATE T, YAMAMOTO S, KATO R: Inhibi-tion of 12-0-tetradecanoylphorbol-13-acetate-mediated epidermal ornithine decarboxylase induction and skin tumor promotion by new lipoxy-genase inhibitors lacking protein kinase C inhibitory effects. Carcinogenesis (1986) 7: 1809-1812.
   Google Scholar
• TSUKADA T, NAKASHIMA K, SHIRAKAWA S: Arachido-nate 5-lipoxygenase inhibitors show potent antiprolif-erative effects on human leukemia cell lines. Biochem. Biophys. Res. Commun. (1986) 140:832–836.
   PubMed Web of Science ®Google Scholar
• ANDERSON KM, SEED T, JAJEH A et al.: An in vivo inhibitor of 5-lipoxygenase, MK886, at micromolar concentration induces apoptosis in U937 and CML cells. Anticancer Res. (1996) 16:2589–2599.
   PubMed Web of Science ®Google Scholar
• PRASIT P, BELLEY M, BLOUIN M et al.: A new class of leukotriene biosynthesis inhibitor: The development of MK-0591.j Lipid MediaL (1993) 6:239–244.
   PubMed Web of Science ®Google Scholar
• HATZELMANN A, FRUCHTMANN R, MOHRS KH, RADDATZ S, MULLER-PEDDINGHAUS R: Mode of action of the new selective leukotriene synthesis inhibitor BAY X-1005 ((R)-2[4-(quinolin-2-yl-methoxy) phenyl]-2-cyclopentyl acetic acid) and structurally related compounds. Biochem. Pharmacol. (1993) 45:101–111.
   PubMed Web of Science ®Google Scholar
• TSAI BS, VILLANI-PRICE D, KEITH RH et al.: SC-41930: An inhibitor of leukotriene B4-stimulated human neutro-phil functions. Prostaglandins (1989) 38:655–674.
   PubMed Web of Science ®Google Scholar
• PENNING TD, DJURIC SW, MIYASHIRO JM et al.: Second-generation leukotriene B4 receptor antagonists related to SC-41930: Heterocyclic replacement of the methyl ketone pharmacophore. J Med. Chem. (1995) 3 8 :858–868.
   Web of Science ®Google Scholar
• MATSUZAKI Y, KUROKAWA N, TERAI S, MATSUMURA Y, KOBAYASHI N, OKITA K: Cell death induced by baicalein in hepatocellular carcinoma cell lines. Jpn. Cancer Res. (1996) 87:170–177.
   Web of Science ®Google Scholar
• HAGMANN W, BORGERS S: Requirement for epidermal growth factor receptor tyrosine kinase and for 12-lipoxygenase activity in the expression of 12-lipoxygenase in human epidermoid carcinoma cells. Biochem. Pharmacol. (1997) 53:937–942.
   PubMed Web of Science ®Google Scholar
• BOCAN TMA, ROSEBURY WS, MUELLER SB et al.: A specific 15-lipoxygenase inhibitor limits the progres-sion and monocyte-macrophage enrichment of hypercholesterolemia-induced atherosclerosis in the rabbit. Atherosclerosis (1998) 136:203–216.
   PubMed Web of Science ®Google Scholar
• STEELE VE, MOON RC, LUBET RA et al: Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: Methods and results from the NCI Chemoprevention Drug Develop-ment Program. J. Cell. Biochem. (1994) 20 (Supple.) :32–54.
   Google Scholar